Artemis Therapeutics Inc. Reports Earnings Results for the Second Quarter Ended June 30, 2021
August 23, 2021 at 12:47 pm EDT
Artemis Therapeutics Inc. announced earnings results for the second quarter ended June 30, 2021. For the second quarter, the company announced operating income was USD 46,000 compared to USD 57,000 a year ago. Net loss was USD 48,000 compared to USD 6,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago. For the half year, operating income was USD 81,000 compared to USD 76,000 a year ago. Net loss was USD 84,000 compared to USD 27,000 a year ago. Basic loss per share from continuing operations was USD 0.01 compared to USD 0.01 a year ago.